Roche has tak­en the Trump pledge, join­ing Pfiz­er, No­var­tis and Mer­ck in promis­ing to hold the line on drug prices

You can add yet an­oth­er Big Phar­ma to the grow­ing list of gi­ants swear­ing off US price hikes.

Roche tells me this morn­ing that they told HHS on Ju­ly 11 — the day af­ter Pfiz­er CEO Ian Read agreed to roll back a price hike in a call with the pres­i­dent — that “we will not be tak­ing any price in­creas­es for the re­main­der of the year.”

Roche’s move comes as Pfiz­er, No­var­tis and Mer­ck have all pledged to hold the line on drug prices for the rest of the year — which comes amid con­sid­er­able skep­ti­cism over just how mean­ing­ful this is. And Reuters is re­port­ing that Bay­er and Mer­ck KGaA are al­so falling in­to line.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.